Detalles de la búsqueda
1.
FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis.
Eur J Nucl Med Mol Imaging
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38750372
2.
Calculation of the estimated glomerular filtration rate using the 2021 CKD-EPI creatinine equation and whole blood creatinine values measured with Radiometer ABL 827 FLEX.
Clin Chem Lab Med
; 60(6): 867-876, 2022 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35427449
3.
Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas.
J Neurooncol
; 152(3): 573-582, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33704629
4.
Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas.
J Neurooncol
; 149(2): 337-346, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32929644
5.
68Ga-FAPI-46 and 18F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors.
Eur J Nucl Med Mol Imaging
; 48(11): 3736-3737, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914106
6.
In vivo quantification of lumbar disc degeneration: assessment of ADC value using a degenerative scoring system based on Pfirrmann framework.
Eur Spine J
; 24(11): 2442-8, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25502000
7.
Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology.
J Surg Oncol
; 109(2): 158-67, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24166728
8.
Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy.
Breast Cancer Res
; 15(1): R14, 2013 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23433249
9.
Effect of taxane-based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR.
NMR Biomed
; 26(12): 1705-13, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23940080
10.
A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for 68Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors.
J Nucl Med
; 63(3): 376-383, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34215673
11.
Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial.
J Nucl Med
; 63(6): 847-854, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649942
12.
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.
Radiology
; 261(3): 735-43, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21878615
13.
Comparison of breast density measured on MR images acquired using fat-suppressed versus nonfat-suppressed sequences.
Med Phys
; 38(11): 5961-8, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22047360
14.
A novel read methodology to evaluate the optimal dose of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trial.
EJNMMI Res
; 11(1): 84, 2021 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34487283
15.
Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden.
Ann Nucl Med
; 35(9): 1022-1029, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34121166
16.
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET.
Cancer Imaging
; 21(1): 27, 2021 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33691798
17.
Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312).
J Nucl Med
; 62(10): 1447-1456, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34272322
18.
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort.
J Nucl Med
; 62(10): 1440-1446, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34016732
19.
Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation.
Radiology
; 255(1): 44-52, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20308443
20.
The Impact of 18F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate Cancer.
Adv Radiat Oncol
; 5(6): 1364-1369, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33305100